-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Nika Pharmaceuticals, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q2 2024.
- Nika Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$8.37K, a 17.5% increase year-over-year.
- Nika Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$109K, a 114% decline year-over-year.
- Nika Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$64.8K, a 98% increase from 2022.
- Nika Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$3.18M, a 21540% decline from 2021.
- Nika Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$14.7K, a 65.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)